A	O
Systematic	B:C1955832
Review	I:C1955832
and	O
Meta-Analysis	O
of	O
the	O
Data	O
Behind	O
Current	O
Recommendations	O
for	O
Corticosteroids	O
in	O
Non-HIV	O
-	I:C1535939
Related	I:C1535939
PCP	I:C1535939
:	O
Knowing	O
When	O
You	O
Are	O
on	O
Shaky	O
Foundations	O
.	O

A	O
Systematic	O
Review	I:C1955832
and	O
Meta-Analysis	B:C0282458
of	O
the	O
Data	O
Behind	O
Current	O
Recommendations	O
for	O
Corticosteroids	O
in	O
Non-HIV	O
-	I:C1535939
Related	I:C1535939
PCP	I:C1535939
:	O
Knowing	O
When	O
You	O
Are	O
on	O
Shaky	O
Foundations	O
.	O

A	O
Systematic	O
Review	I:C1955832
and	O
Meta-Analysis	O
of	O
the	O
Data	O
Behind	O
Current	O
Recommendations	O
for	O
Corticosteroids	B:C0001617
in	O
Non-HIV	O
-	I:C1535939
Related	I:C1535939
PCP	I:C1535939
:	O
Knowing	O
When	O
You	O
Are	O
on	O
Shaky	O
Foundations	O
.	O

A	O
Systematic	O
Review	I:C1955832
and	O
Meta-Analysis	O
of	O
the	O
Data	O
Behind	O
Current	O
Recommendations	O
for	O
Corticosteroids	O
in	O
Non-HIV	B:C1535939
-	I:C1535939
Related	I:C1535939
PCP	I:C1535939
:	O
Knowing	O
When	O
You	O
Are	O
on	O
Shaky	O
Foundations	O
.	O

Randomized	B:C0206034
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	O
corticosteroids	I:C0001617
for	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	O
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	O
)	O
.	O

Randomized	O
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	B:C0001617
corticosteroids	I:C0001617
for	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	O
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	O
)	O
.	O

Randomized	O
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	O
corticosteroids	I:C0001617
for	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	O
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	O
)	O
.	O

Randomized	O
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	O
corticosteroids	I:C0001617
for	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	O
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	O
)	O
.	O

Randomized	O
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	O
corticosteroids	I:C0001617
for	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	B:C1535939
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	O
)	O
.	O

Randomized	O
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	O
corticosteroids	I:C0001617
for	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	O
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	O
)	O
.	O

Randomized	O
trials	I:C0206034
show	O
a	O
mortality	O
benefit	O
to	O
adjunctive	O
corticosteroids	I:C0001617
for	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
-	O
related	O
Pneumocystis	O
jiroveci	I:C1535939
pneumonia	I:C1535939
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
PCP	B:C1535939
)	O
.	O

Guidelines	B:C0162791
for	O
non-HIV	O
PCP	I:C1535939
(	O
non	O
-	I:C1535939
HIV	I:C1535939
PCP	I:C1535939
)	O
recommend	O
adjunctive	O
corticosteroids	I:C0001617
based	O
on	O
expert	O
opinion	O
.	O

Guidelines	O
for	O
non-HIV	B:C1535939
PCP	I:C1535939
(	O
non	O
-	I:C1535939
HIV	I:C1535939
PCP	I:C1535939
)	O
recommend	O
adjunctive	O
corticosteroids	I:C0001617
based	O
on	O
expert	O
opinion	O
.	O

Guidelines	O
for	O
non-HIV	O
PCP	I:C1535939
(	O
non	B:C1535939
-	I:C1535939
HIV	I:C1535939
PCP	I:C1535939
)	O
recommend	O
adjunctive	O
corticosteroids	I:C0001617
based	O
on	O
expert	O
opinion	O
.	O

Guidelines	O
for	O
non-HIV	O
PCP	I:C1535939
(	O
non	O
-	I:C1535939
HIV	I:C1535939
PCP	I:C1535939
)	O
recommend	O
adjunctive	B:C0001617
corticosteroids	I:C0001617
based	O
on	O
expert	O
opinion	O
.	O

We	O
conducted	O
a	O
systematic	B:C1955832
review	I:C1955832
and	O
meta-	O
analysis	I:C0282458
characterizing	O
adjunctive	O
corticosteroids	I:C0001617
for	O
non-HIV	O
PCP	I:C1535939
.	O

We	O
conducted	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	B:C0282458
analysis	I:C0282458
characterizing	O
adjunctive	O
corticosteroids	I:C0001617
for	O
non-HIV	O
PCP	I:C1535939
.	O

We	O
conducted	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	O
analysis	I:C0282458
characterizing	O
adjunctive	B:C0001617
corticosteroids	I:C0001617
for	O
non-HIV	O
PCP	I:C1535939
.	O

We	O
conducted	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	O
analysis	I:C0282458
characterizing	O
adjunctive	O
corticosteroids	I:C0001617
for	O
non-HIV	B:C1535939
PCP	I:C1535939
.	O

We	O
searched	O
MEDLINE	B:C0025141
from	O
1966	O
through	O
2015	O
.	O

Data	O
on	O
clinical	O
outcomes	O
from	O
non-HIV	B:C1535939
PCP	I:C1535939
were	O
extracted	O
with	O
a	O
standardized	O
instrument	O
.	O

Heterogeneity	O
was	O
assessed	O
with	O
the	O
I	B:C0918012
(	I:C0918012
2	I:C0918012
)	I:C0918012
index	I:C0918012
.	O

Pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
interval	O
were	O
calculated	O
using	O
a	O
fixed	B:C0026348
effects	I:C0026348
model	I:C0026348
.	O

Our	O
search	O
yielded	O
5044	O
abstracts	B:C0600678
,	O
277	O
articles	O
were	O
chosen	O
for	O
full	O
review	O
,	O
and	O
6	O
articles	O
described	O
outcomes	O
in	O
moderate	O
to	O
severe	O
non-HIV	O
PCP	I:C1535939
.	O

Our	O
search	O
yielded	O
5044	O
abstracts	O
,	O
277	O
articles	B:C0282420
were	O
chosen	O
for	O
full	O
review	O
,	O
and	O
6	O
articles	O
described	O
outcomes	O
in	O
moderate	O
to	O
severe	O
non-HIV	O
PCP	I:C1535939
.	O

Our	O
search	O
yielded	O
5044	O
abstracts	O
,	O
277	O
articles	O
were	O
chosen	O
for	O
full	O
review	O
,	O
and	O
6	O
articles	B:C0282420
described	O
outcomes	O
in	O
moderate	O
to	O
severe	O
non-HIV	O
PCP	I:C1535939
.	O

Our	O
search	O
yielded	O
5044	O
abstracts	O
,	O
277	O
articles	O
were	O
chosen	O
for	O
full	O
review	O
,	O
and	O
6	O
articles	O
described	O
outcomes	O
in	O
moderate	O
to	O
severe	O
non-HIV	B:C1535939
PCP	I:C1535939
.	O

Studies	B:C2603343
were	O
limited	O
by	O
variable	O
definitions	O
,	O
treatment	O
selection	O
bias	O
,	O
concomitant	O
infections	O
and	O
small	O
sample	O
size	O
.	O

Studies	O
were	O
limited	O
by	O
variable	O
definitions	O
,	O
treatment	B:C0087111
selection	O
bias	O
,	O
concomitant	O
infections	O
and	O
small	O
sample	O
size	O
.	O

Studies	O
were	O
limited	O
by	O
variable	O
definitions	O
,	O
treatment	O
selection	O
bias	O
,	O
concomitant	O
infections	B:C3714514
and	O
small	O
sample	O
size	O
.	O

Individual	B:C0237401
studies	O
reported	O
shorter	O
intensive	O
care	I:C0021708
unit	I:C0021708
stay	O
and	O
duration	O
of	O
mechanical	O
ventilation	I:C0199470
of	O
patients	O
given	O
adjunctive	O
corticosteroids	I:C0001617
.	O

Individual	O
studies	B:C2603343
reported	O
shorter	O
intensive	O
care	I:C0021708
unit	I:C0021708
stay	O
and	O
duration	O
of	O
mechanical	O
ventilation	I:C0199470
of	O
patients	O
given	O
adjunctive	O
corticosteroids	I:C0001617
.	O

Individual	O
studies	O
reported	O
shorter	O
intensive	B:C0021708
care	I:C0021708
unit	I:C0021708
stay	O
and	O
duration	O
of	O
mechanical	O
ventilation	I:C0199470
of	O
patients	O
given	O
adjunctive	O
corticosteroids	I:C0001617
.	O

Individual	O
studies	O
reported	O
shorter	O
intensive	O
care	I:C0021708
unit	I:C0021708
stay	O
and	O
duration	O
of	O
mechanical	B:C0199470
ventilation	I:C0199470
of	O
patients	O
given	O
adjunctive	O
corticosteroids	I:C0001617
.	O

Individual	O
studies	O
reported	O
shorter	O
intensive	O
care	I:C0021708
unit	I:C0021708
stay	O
and	O
duration	O
of	O
mechanical	O
ventilation	I:C0199470
of	O
patients	O
given	O
adjunctive	B:C0001617
corticosteroids	I:C0001617
.	O

There	O
was	O
no	O
association	O
between	O
corticosteroids	B:C0001617
and	O
survival	O
in	O
non-HIV	O
PCP	I:C1535939
(	O
odds	O
ratio	O
,	O
0.66	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0.38	O
-	O
1.15	O
;	O
P	O
=	O
0.14	O
)	O
.	O

There	O
was	O
no	O
association	O
between	O
corticosteroids	O
and	O
survival	O
in	O
non-HIV	B:C1535939
PCP	I:C1535939
(	O
odds	O
ratio	O
,	O
0.66	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0.38	O
-	O
1.15	O
;	O
P	O
=	O
0.14	O
)	O
.	O

The	O
literature	B:C0034036
does	O
not	O
support	O
an	O
association	O
between	O
adjunctive	O
corticosteroids	I:C0001617
and	O
survival	O
from	O
non-HIV	O
PCP	I:C1535939
but	O
data	O
are	O
limited	O
and	O
findings	O
should	O
not	O
be	O
considered	O
conclusive	O
.	O

The	O
literature	O
does	O
not	O
support	O
an	O
association	O
between	O
adjunctive	B:C0001617
corticosteroids	I:C0001617
and	O
survival	O
from	O
non-HIV	O
PCP	I:C1535939
but	O
data	O
are	O
limited	O
and	O
findings	O
should	O
not	O
be	O
considered	O
conclusive	O
.	O

The	O
literature	O
does	O
not	O
support	O
an	O
association	O
between	O
adjunctive	O
corticosteroids	I:C0001617
and	O
survival	O
from	O
non-HIV	B:C1535939
PCP	I:C1535939
but	O
data	O
are	O
limited	O
and	O
findings	O
should	O
not	O
be	O
considered	O
conclusive	O
.	O

Further	O
research	B:C0035168
with	O
improved	O
methodology	O
is	O
needed	O
to	O
better	O
understand	O
the	O
role	O
of	O
adjunctive	O
corticosteroids	I:C0001617
for	O
non-HIV	O
PCP	I:C1535939
.	O

Further	O
research	O
with	O
improved	O
methodology	O
is	O
needed	O
to	O
better	O
understand	O
the	O
role	O
of	O
adjunctive	B:C0001617
corticosteroids	I:C0001617
for	O
non-HIV	O
PCP	I:C1535939
.	O

Further	O
research	O
with	O
improved	O
methodology	O
is	O
needed	O
to	O
better	O
understand	O
the	O
role	O
of	O
adjunctive	O
corticosteroids	I:C0001617
for	O
non-HIV	B:C1535939
PCP	I:C1535939
.	O

